NCT06275919
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06275919
Title Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)
Acronym MIRAGE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Oncologico Veneto IRCCS
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
IRST Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" RECRUITING Meldola Forlì-Cesena Italy Details
Azienda Ospedaliera Universitaria Gaetano Martino NOT_YET_RECRUITING Messina Italia/Messina 98124 Italy Details
Humanitas Cancer Center RECRUITING Rozzano Milano Italy Details
Ospedale San Paolo RECRUITING Bari Italy Details
Ospedale Bellaria - AUSL Bologna RECRUITING Bologna Italy Details
Azienda Ospedaliero Universitaria Careggi RECRUITING Florence Italy Details
Policlinico San Martino RECRUITING Genova Italy Details
Spedali Riuniti RECRUITING Livorno Italy Details
Fondazione IRCCS Istituto Neurologico Carlo Besta RECRUITING Milan Italy Details
IRCCS Ospedale San Raffaele RECRUITING Milan Italy Details
Ospedale del Mare RECRUITING Napoli Italy Details
Istituto Oncologico Veneto RECRUITING Padua 35128 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli IRCCS NOT_YET_RECRUITING Roma Italy Details
IRCCS Istituto Tumori Regina Elena RECRUITING Roma Italy Details
Policlinico Umberto I - Università Sapienza Roma NOT_YET_RECRUITING Roma Italy Details
A.O.U. Città della Salute e della Scienza di Torino RECRUITING Torino Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field